• Projects
  • Biventricular Epicardial Augmentation Technology

Biventricular Epicardial Augmentation Technology | A revolutionary technology platform for providing life-saving treatment for end-stage heart failure patients

Summary
Over 500K patients in the EU and US suffer from end-stage heart failure (HF), with a life expectancy of
Resources Show all and search (2)
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/190170931
Start date: 01-01-2023
End date: 31-12-2024
Total budget - Public funding: 3 912 949,25 Euro - 2 499 999,00 Euro
Cordis data

Original description

Over 500K patients in the EU and US suffer from end-stage heart failure (HF), with a life expectancy of

Status

SIGNED

Call topic

HORIZON-EIC-2022-ACCELERATOROPEN-01

Update Date

09-02-2023
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
Horizon Europe
HORIZON.3 Innovative Europe
HORIZON.3.1 The European Innovation Council (EIC)
HORIZON.3.1.0 Cross-cutting call topics
HORIZON-EIC-2022-ACCELERATOR-01
HORIZON-EIC-2022-ACCELERATOROPEN-01 EIC Accelerator Open
Search
Search on Google
Search on Bing
Search on DuckDuckGo
Organisations
Show all (1)
Powered by Chris Decubber BV